Developed on the SBTDC’s successful “Becoming an Investor-Ready Entrepreneur” (IRE) framework, this inaugural pharmaceutical development focused version of IRE will provide an insider’s look into the world of raising equity capital for pre-clinical stage entrepreneurs, university startups, faculty, and other ecosystems stakeholders.
Are YOU an investor-ready entrepreneur?
Raising equity capital is challenging at best for any company. Drug development companies face a unique challenge due to the incredibly high-level of risk and capital required to advance drugs though FDA clinical trials. Becoming an Investor-Ready Entrepreneur (IRE) is designed to educate and prepare pre-clinical stage entrepreneurs to successfully engage private equity investors.
This program was developed by experienced entrepreneurs, venture capital investors, and drug development stakeholders, to provide an “insider’s look” into the world of equity funding.